Status:

ACTIVE_NOT_RECRUITING

A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.

Lead Sponsor:

National University Hospital, Singapore

Conditions:

Metastatic Pancreatic Ductal Adenocarcinoma

Eligibility:

All Genders

21-99 years

Phase:

PHASE1

Brief Summary

This is a single-center, pilot study evaluating the addition of Ciprofloxacin (study drug) to standard-of-care gemcitabine and nab-paclitaxel chemotherapy in treatment-naïve metastatic PDAC patients. ...

Detailed Description

Oral ciprofloxacin (study drug) will be administered twice a day throughout each 28-day cycle of gemcitabine and nab-paclitaxel chemotherapy. The patient will start taking ciprofloxacin from the eveni...

Eligibility Criteria

Inclusion

  • Signed informed consent. Written informed consent must be obtained prior to performing any study-related procedures.
  • Age ≥ 21 years
  • Histologically or cytologically confirmed, treatment-naïve, locally advanced or metastatic pancreatic adenocarcinoma planned to commence on gemcitabine and nab-paclitaxel chemotherapy.
  • Patient must have measurable disease as defined by the Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST v 1.1 guidelines)
  • Life expectancy \>3 months
  • Eastern Cooperative Oncology Group (ECOG) performance status of 0-2
  • CrCl ≥ 30 ml/min

Exclusion

  • Known hypersensitivity or allergy to ciprofloxacin or other quinolones
  • On tizanidine or theophylline and unable to stop these medication
  • Known QTc prolongation (QTc \>500 msec) or torsade de pointes
  • Presence of Clostridium difficile-associated diarrhea or colitis
  • Known history of myasthenia gravis
  • Known G6PD deficiency

Key Trial Info

Start Date :

February 22 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2027

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT04523987

Start Date

February 22 2019

End Date

February 1 2027

Last Update

September 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National University Hospital

Singapore, Singapore

A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma. | DecenTrialz